Copyright 2018
"Dec 8, 2017 · Our Mission. We bring late stage pharma products to market that are undervalued or need experienced leadership to monetize. About Us. Investors. Marizyme will reduce investor risk and seek partners with advantages in ..."
"We are a biotechnology company with clinically tested and patented use of proteolytic enzyme therapy for the treatment of chronic wounds, thrombolysis and dental health. We call our treatment Krillase®. We are focused on bringing late stage ..."
http://marizyme.com
"" "" are snippets I could see doing a Google search.
Website is being created but these snippets could still be seen in the website description on the Google query page but not when you go to the actual site.
Also, marizyme products already on Amazon!?!?!? Possibly??? If it's the same company.
$$$$$$$$$$$$GBSX$$$$$$$$$$$$$$$
Recent MRZM News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/28/2024 08:23:06 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 05/15/2024 08:05:32 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 05/13/2024 08:50:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2024 09:00:41 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 02/06/2024 09:15:22 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/06/2024 01:55:47 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 12/29/2023 10:15:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/29/2023 01:06:45 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/28/2023 11:02:41 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 11/22/2023 09:36:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/21/2023 09:15:34 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 11/16/2023 11:08:53 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2023 09:27:51 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 10/24/2023 08:15:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2023 01:08:33 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/23/2023 01:15:17 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 10/18/2023 04:15:10 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 10/17/2023 09:10:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/06/2023 01:15:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/04/2023 08:15:29 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/07/2023 09:12:41 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/05/2023 08:15:45 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/18/2023 08:05:53 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/15/2023 08:15:23 PM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM
Element79 Gold Corp Files for OTCQB Uplisting, Provides Financial Update • ELEM • Jun 11, 2024 9:25 AM